PRME
Price
$1.66
Change
-$0.09 (-5.14%)
Updated
Apr 25, 02:44 PM (EDT)
Capitalization
229.53M
14 days until earnings call
TCRX
Price
$1.63
Change
-$0.09 (-5.23%)
Updated
Apr 25, 02:38 PM (EDT)
Capitalization
97.34M
18 days until earnings call
Ad is loading...

PRME vs TCRX

Header iconPRME vs TCRX Comparison
Open Charts PRME vs TCRXBanner chart's image
Prime Medicine
Price$1.66
Change-$0.09 (-5.14%)
Volume$5.03K
Capitalization229.53M
TScan Therapeutics
Price$1.63
Change-$0.09 (-5.23%)
Volume$111
Capitalization97.34M
PRME vs TCRX Comparison Chart
Loading...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRME vs. TCRX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRME is a Buy and TCRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (PRME: $1.75 vs. TCRX: $1.72)
Brand notoriety: PRME and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRME: 57% vs. TCRX: 71%
Market capitalization -- PRME: $229.53M vs. TCRX: $97.34M
PRME [@Biotechnology] is valued at $229.53M. TCRX’s [@Biotechnology] market capitalization is $97.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRME’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 0 green FA rating(s).

  • PRME’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 0 green, 5 red.
According to our system of comparison, TCRX is a better buy in the long-term than PRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRME’s TA Score shows that 4 TA indicator(s) are bullish while TCRX’s TA Score has 4 bullish TA indicator(s).

  • PRME’s TA Score: 4 bullish, 4 bearish.
  • TCRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PRME is a better buy in the short-term than TCRX.

Price Growth

PRME (@Biotechnology) experienced а +41.13% price change this week, while TCRX (@Biotechnology) price change was +19.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.17%. For the same industry, the average monthly price growth was -4.24%, and the average quarterly price growth was -12.55%.

Reported Earning Dates

PRME is expected to report earnings on May 09, 2025.

TCRX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+7.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($230M) has a higher market cap than TCRX($97.3M). PRME YTD gains are higher at: -40.068 vs. TCRX (-43.421). TCRX has higher annual earnings (EBITDA): -119.74M vs. PRME (-196.34M). TCRX has more cash in the bank: 290M vs. PRME (190M). PRME has less debt than TCRX: PRME (40.8M) vs TCRX (97.4M). PRME has higher revenues than TCRX: PRME (2.98M) vs TCRX (2.82M).
PRMETCRXPRME / TCRX
Capitalization230M97.3M236%
EBITDA-196.34M-119.74M164%
Gain YTD-40.068-43.42192%
P/E RatioN/AN/A-
Revenue2.98M2.82M106%
Total Cash190M290M66%
Total Debt40.8M97.4M42%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
64

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRMETCRX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
Bearish Trend 22 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PXNIX11.14N/A
N/A
Impax International Sust Econ Instl
FTSIX34.27N/A
N/A
FullerThaler Behvrl S-M Cor Eq Instl
LHCSX17.63N/A
N/A
Lord Abbett Health Care R4
IRCIX11.73N/A
N/A
Voya Russell Small Cap Index Port S2
FIQWX16.36N/A
N/A
Fidelity Advisor Strategic Div & Inc Z

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
-1.69%
CRSP - PRME
63%
Loosely correlated
+1.48%
BEAM - PRME
59%
Loosely correlated
+1.51%
RXRX - PRME
59%
Loosely correlated
+3.05%
NTLA - PRME
57%
Loosely correlated
+1.11%
ABCL - PRME
53%
Loosely correlated
+2.77%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with PRME. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
+5.52%
PRME - TCRX
46%
Loosely correlated
-1.69%
FATE - TCRX
44%
Loosely correlated
+1.50%
IMNM - TCRX
43%
Loosely correlated
+0.24%
SYRE - TCRX
42%
Loosely correlated
+4.99%
RGNX - TCRX
41%
Loosely correlated
+3.72%
More